Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
PNPLA2 encodes an enzyme which catalyzes the first step in the hydrolysis of triglycerides in adipose tissue. Additionally we are shipping Patatin-Like phospholipase Domain Containing 2 Kits (39) and Patatin-Like phospholipase Domain Containing 2 Proteins (9) and many more products for this protein.
Showing 10 out of 176 products:
Human Polyclonal PNPLA2 Primary Antibody for IHC (p), IHC - ABIN252920
Schoenborn, Heid, Vollmert, Lingenhel, Adams, Hopkins, Illig, Zimmermann, Zechner, Hunt, Kronenberg: The ATGL gene is associated with free fatty acids, triglycerides, and type 2 diabetes. in Diabetes 2006
Human Polyclonal PNPLA2 Primary Antibody for ELISA, WB - ABIN314328
Steinberg, Kemp, Watt: Adipocyte triglyceride lipase expression in human obesity. in American journal of physiology. Endocrinology and metabolism 2007
Polyclonal PNPLA2 Primary Antibody for WB - ABIN540337
Haemmerle, Lass, Zimmermann, Gorkiewicz, Meyer, Rozman, Heldmaier, Maier, Theussl, Eder, Kratky, Wagner, Klingenspor, Hoefler, Zechner: Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase. in Science (New York, N.Y.) 2006
Human Monoclonal PNPLA2 Primary Antibody for ELISA, IHC - ABIN449788
Mason, Meex, Russell, Canny, Watt: Cellular localization and associations of the major lipolytic proteins in human skeletal muscle at rest and during exercise. in PLoS ONE 2014
Human Monoclonal PNPLA2 Primary Antibody for CyTOF, FACS - ABIN4899287
He, Wu, Gong, Luo, Zhang, Li, Lu, Wei, Yang: Enhanced efficacy of combination therapy with adeno‑associated virus-delivered pigment epithelium-derived factor and cisplatin in a mouse model of Lewis lung carcinoma. in Molecular medicine reports 2014
the ATGL gene plays an important role in triglyceride lipolysis in GMECs; ATGL may be involved in lipid metabolism during lactation
a Snail1 (show SNAI1 Antibodies)-ATGL axis that regulates adipose lipolysis and fatty acid release, is reported.
ABHD5 (show ABHD5 Antibodies) possesses a PNPLA2-independent function in regulating autophagy and tumorigenesis.
Oxidative stress decreased the levels of PNPLA2 transcripts with no effect on ALOX5 (show ALOX5 Antibodies) expression. Exogenous additions of P1 peptide or overexpression of the PNPLA2 gene decreased both LTB4 (show PTGR1 Antibodies) levels and death of RPE (show RPE Antibodies) cells undergoing oxidative stress.
Results suggest that increased adipose triglyceride lipase (ATGL) expression is associated with increased adiposity and stromal proliferation in patients with pancreatic ductal adenocarcinoma (PDAC).
A missense mutation in PNPLA2 is the rare cause of severe dilated cardiomyopathy secondary to neutral lipid storage disease.
A novel deletion was identified in PNPLA2 protein from a patient with complete deficiency of adipose triglyceride lipase.
Rab32 (show RAB32 Antibodies) controls intracellular lipid accumulation through inducing lipolysis via enhancing ATGL expression indirectly.
Data indicate that a tumor suppressor mechanism by which G0/G1 switch gene 2 (show G0S2 Antibodies) product (G0S2 (show G0S2 Antibodies)) directly inhibits activity of a key intracellular adipose triglyceride lipase (ATGL).
Authors show that rat ATGL, coactivated by rat CGI-58 (show ABHD5 Antibodies), efficiently hydrolyzes triglycerides and retinyl ester.
PNPLA2 mutations were associated with an extended phenotype, including brain involvement in cases of neutral lipid-storage disease with myopathy.
CGI-58 (show ABHD5 Antibodies) regulates hepatic neutral lipid storage and inflammation in the genetic absence of ATGL.
Enhanced lipolysis in response to mitochondrial uncoupling relies on a form of autophagy as lipid droplets are captured by endolysosomal vesicles which is HSL (show LIPE Antibodies)/ATGL-independent.
The Atgl is down-regulated by the basal transcription factor Sp1 (show SP1 Antibodies) in preadipocytes and that the magnitude of down-regulation depends on interactions between Sp1 (show SP1 Antibodies) and peroxisome proliferator-activated receptor gamma (PPARgamma (show PPARG Antibodies)).
TAG synthesis and levels of PUFA-TAGs were lowered by the diacylglycerol acyltransferase (DGAT)1 (show DGAT1 Antibodies) inhibitor, T863. The lipase (show LIPG Antibodies) inhibitor, Atglistatin, increased the levels of TAG in both WT and ATGL-deficient mouse Hepatic stellate cell (HSC (show FUT1 Antibodies)). Both Atglistatin and T863 inhibited the induction of activation marker, alpha-smooth muscle actin (show ACTG2 Antibodies), in rat HSCs, but not in mouse HSCs.
G0S2 (show G0S2 Antibodies) protein but not mRNA levels were reduced in the adipose tissue of ATGL-deficient mice, corroborating the involvement of ATGL in the stabilization of G0S2 (show G0S2 Antibodies)
Atgl deficiency induces podocyte apoptosis and leads to glomerular filtration barrier damage.
These data raise the possibility that ATGL deficiency could impair the renal fatty acid metabolism though inhibiting PPARalphaexpression, which may lead to lipid deposition and cell apoptosis of PCT (show UROD Antibodies), and finally contribute to the renal fibrosis and dysfunction
Markers of mitochondrial content and respiration were increased in adipose tissue from ATGL knockout mice.
ase (show ARSE Antibodies). Similar changes of GPNMB and G0S2 (show G0S2 Antibodies) expression were present in a human liposarcoma database. These results show that a previously-unknown, fully penetrant epistatic interaction between Pnpla2 and Lipe (show LIPE Antibodies) can cause liposarcoma in mice. DAKO mice provide a promising model for studying early premalignant changes that lead to late-onset malignant disease.
Results identified functional polymorphisms providing new evidence of PNPLA2 as an important candidate gene for fat deposition and carcass traits in pigs.
Resveratrol activated sirtuin 1 (Sirt1 (show SIRT1 Antibodies)) gene expression and increased adipose triglyceride lipase (ATGL) gene expression and glycerol release. Furthermore, this study found the opposite Sirt1 (show SIRT1 Antibodies) regulation pattern for PPARgamma (show PPARG Antibodies) to that of ATGL in adipocytes.
analysis of porcine adipose triglyceride lipase (PNPLA2) gene
JAK (show JAK3 Antibodies)-STAT (show STAT1 Antibodies) and MAPK (show MAPK1 Antibodies) signaling pathways, as well as PPAR gamma (show PPARG Antibodies) all played important roles in the ATGL expression mediated by leptin (show LEP Antibodies)
patatin-like phospholipase domain containing 2 gene (PNPLA2) is assiged to chromosome 2 in pigs.
ATGL expression reacts to hormonal stimuli and plays a role in catecholamine-induced lipolysis in porcine adipose tissue.
Tissue distribution of ATGL gene expression was highest in fat and muscle (skeletal and cardiac) tissue, while protein expression was solely detectible in the adipose tissue.
This gene encodes an enzyme which catalyzes the first step in the hydrolysis of triglycerides in adipose tissue. Mutations in this gene are associated with neutral lipid storage disease with myopathy.
patatin-like phospholipase domain-containing protein 2
, patatin-like phospholipase domain containing 2
, adipose triglyceride lipase
, calcium-independent phospholipase A2
, patatin-like phospholipase domain containing protein 2
, pigment epithelium-derived factor
, transport-secretion protein 2.2
, triglyceride hydrolase
, transport-secretion protein